A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine

J Med Virol. 2021 Dec;93(12):6468-6470. doi: 10.1002/jmv.27247. Epub 2021 Aug 10.

Authors

Serena Messali¹, Anna Bertelli¹, Giovanni Campisi¹, Alberto Zani¹, Massimo Ciccozzi², Arnaldo Caruso¹, Francesca Caccuri¹

Affiliations

¹ Section of Microbiology Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
² Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, Rome, Italy.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Neutralizing / immunology*
Antibodies, Viral / immunology*
BNT162 Vaccine
COVID-19 / prevention & control*
COVID-19 Vaccines / immunology*
Humans
Italy
Neutralization Tests
SARS-CoV-2 / genetics
SARS-CoV-2 / immunology*
SARS-CoV-2 / isolation & purification

Substances

Antibodies, Neutralizing
Antibodies, Viral
COVID-19 Vaccines
BNT162 Vaccine